Vyome Holdings HIND
NASDAQ HIND
$1.84 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) EV to CFO (2025)

Updated

Vyome Holdings' (HIND) EV to CFO was -0.59 for Q2 2025.

Analysis

Vyome Holdings (HIND) EV to CFO (2025) Analysis & Trends

Over the twelve months ended Jun 30, 2025, Vyome Holdings' EV to CFO came in at -2.14.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Vyome Holdings 13.12 Mn -14.25 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -0.59
Mar 31, 2025 -1.53
API Access

Vyome Holdings EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=HIND&period=max&api_key=YOUR_API_KEY